|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 275, Issue 15, 10859-10863, April 14, 2000
From the The Shaker superfamily encodes voltage-gated
potassium (Kv) channels. The N termini of Shaker proteins are located
intracellularly and contain several domains shown to regulate important
aspects of channel function, such as speed of inactivation, channel
assembly (T1 domain), and steady state protein level (T0 domain, amino acids 3-39 in rabbit). Mutations and/or deletion of certain amino acids in the T0 domain lead to a 13-fold amplification of Kv current as
compared with wild type channels, primarily by increasing the absolute
number of channel proteins present in the membrane (Segal, A. S.,
Yao, X., and Desir, G. V. (1999) Biochem. Biophys. Res. Commun. 254, 54-64). Although T0 mutants have kinetic properties virtually indistinguishable from wild type, they were noted to have a
slightly larger single channel conductance, suggesting that the T0
domain might also interact with the pore region. In the present study
we show that although T0 does not affect pore selectivity, it does
modulate the binding affinity of the pore blocker, charybdotoxin. These
results suggest that the N terminus of Kv1.3 is closely associated with
the pore region.
The Shaker gene superfamily consists of at least 10 families
(Kv1-Kv10) that encode voltage-gated potassium (Kv) channels. All Kv
genes cloned so far code for proteins with identical secondary structures: intracellular localization of N and C termini, six transmembrane segments (S1-S6), a voltage sensor (S4), and a pore (P)
region. The S4 segment senses changes in membrane voltage (1-4). Ion
permeation occurs via the P region located between the fifth and sixth
transmembrane segments (5-8). This is also the region that binds the
channel blockers tetraethylammonium and charybdotoxin (9, 10). The
structure of a potassium channel pore was recently determined from
crystallographic data obtained from a potassium channel protein
isolated from Streptomyces lividans (11). In brief, the
channel is a homotetramer and its pore resembles an inverted cone with
a narrow selectivity filter and a large, intracellular, water filled
cavity. Because each Kv subfamily has distinctive kinetic properties,
structure-function relationships of Kv proteins have been extensively
studied using naturally occurring isoforms and mutants obtained by
site-directed mutagenesis. The extreme N terminus mediates rapid
inactivation (12, 13) in Kv proteins that inactivate quickly. A more
distal N-terminal region known as the T1 domain regulates channel
assembly (14-16) by serving as a recognition site for heteromultimeric
channel assembly within a family and by preventing co-assembly between families.
Shaker Kv1.3 is expressed in brain, lymphocytes, and kidney, and there
are excellent data showing that the Kv1.3 subfamily mediates the n type
current of T lymphocytes (17, 18). The 20-fold rise in n type current
that occurs upon T cell activation (19-21) is accompanied by an
increase in Kv1.3 protein density at the plasma membrane, despite a
decrease in steady state mRNA level (18). Moreover, the kinetics of
activation/inactivation and voltage sensitivity of the n current do not
change in activated T lymphocytes. Conversely, blockers of the n
current inhibit mitogen-induced cell division and secretion of
interleukin 2.
We recently identified an N-terminal region of Shaker Kv1.3 (T0 domain,
amino acids 3-39 of rabbit Kv1.3) that modulates channel expression.
Deletion of T0 increases whole cell current by more than 10-fold (22).
Site-directed mutagenesis studies suggest that negatively charged amino
acids are essential components of the T0 domain. Although the deletion
amplifies the magnitude of expressed currents, it affects neither the
time constants of activation and inactivation nor the voltage
dependence. A slight increase in single channel conductance was noted
in the mutant, but it could not account for the observed
gain-of-function. Rather, the change in T0 mutant current was caused
largely by a dramatic increase in channel protein at the plasma
membrane (23). The molecular mechanisms mediating this change in steady
state protein level are still being investigated but do not appear
to involve clathrin-mediated endocytosis (22).
Because a small increase in single channel conductance was noted in T0
mutants, it was hypothesized the T0 domain might also interact with the
pore region. We find that although T0 mutations do not affect pore
selectivity, they do modulate the affinity of channel blockers binding
to the extracellular surface of the pore region.
Generation of Mutant Channels--
The NT3-39 mutant was
generated by deleting the DNA sequence coding for amino acids 3-39
from wild type rabbit Kv1.3 (GenBankTM accession
number U38240) DNA using polymerase chain reaction (see Fig. 1).
The sense primer
(GGATCCTAATACGACTCACTATAGGGAGGAGCCACCATGACGGAGCAGGAGTGCTGCGGGGAG) contained a T7 polymerase site and the coding sequence for amino acids
1-2 and 40-51. The antisense primer (TTTTTTTTTCCTGTCCTTGATGGATGGTCT) contained a stop codon and a poly(A) tail. NT3-39 was amplified by polymerase chain reaction using an Air Thermo Cycler 1605 (Idaho Technologies). The amplified product was cloned into pBluescript and
sequenced by the method of Sanger et al. (24) to confirm that no other mutations besides the 3-39 deletion were introduced during the amplification process. Two other mutants, NT3-27 and NT3-37* were generated as described previously (22).
Expression in Xenopus Oocytes--
Stage V-VI Xenopus
laevis oocytes were dissected from ovarian lobes and stored
in modified Barth's solution. Oocytes were injected with 50 nl
containing either 5 ng of in vitro transcribed, 5'-capped
rabKv1.3 (WT)1 RNA, 5 ng of
NT3-39 (mutated) RNA, 5 ng of WT/5 ng of mutated RNA, or water as a
negative control. Whole cell currents were recorded using a standard
two-microelectrode voltage clamp (OC-725, Warner Inst.) 1-3 days after
injection. Oocytes were impaled with microelectrodes filled with 0.5 M KCl (resistance, 0.5-5 M Deletion of the T0 domain, mutant NT3-39 (Fig.
1A) was previously shown to
cause a 13-fold increase in Kv1.3 current expressed in
Xenopus oocytes (22). To confirm these results, cRNA of wild type or mutants was injected in Xenopus oocytes, and channel
expression was analyzed using two-microelectrode voltage clamp and
patch clamp. NT3-39 cRNA caused a large increase in whole cell current 3 days post-injection as compared with wild type cRNA as shown in the
current-voltage (I-V) plot for peak currents (Fig. 1B). Peak
current at +80 mV was 1.35 ± 0.28 µA (n = 8)
for wild type as compared with 31.22 ± 8.4 µA
(n = 8) for NT3-39 mutant (p < 0.0001).
Patch clamp recordings of wild type and NT3-39 single channels showed
the unitary conductance was slightly increased in the mutant: between
To detect possible interactions of the T0 domain with the pore region,
we first tested whether T0 domain mutations affected cation
selectivity. To estimate the selectivity of WT and NT3-39 mutants with
respect to potassium, rubidium, and sodium, tail currents were examined
at voltages ranging from We then asked whether the T0 domain could modulate the affinity of the
channel blocker, charybdotoxin (CTX). CTX is a 37-amino acid peptide
isolated from the venom of the scorpion Leirus
quinquestriatus. It inhibits several types of potassium channels,
including Kv1.3, at nanomolar concentration (9, 26) by binding to the
extracellular face of the pore region, with a one-to-one stoichiometry
and occluding the "mouth" of the channel. High affinity binding of
CTX is critically dependent on electrostatic interactions of the
positively charged toxin with negatively charged amino acid residues
located at the mouth of the channel. Indeed, in Drosophila
Shaker, binding affinity is reduced by a factor of 3.5 by mutating
glutamate 422 to glutamine and by a factor of 12 by substituting lysine
(9). We measured the effect of CTX on WT Kv1.3 and NT3-39 expressed in
oocytes. Although 1 nM CTX inhibited WT current by 60%, in
good agreement with published IC50 values ranging from 0.5 to 20 nM for human, mouse, and rat Kv1.3, NT3-39 currents
were insensitive to inhibition by 1 nM CTX. The dose
response curves for WT and NT3-39 were then determined (Fig.
2). Compared with WT, NT3-39 is 20-fold
less sensitive to inhibition by CTX (Ki of 0.5 nM versus 9.3 nM).
It has been reported that the properties of Kv1.3 currents can vary depending on the cRNA concentration level injected in oocytes (27). For instance, at low Kv1.3 cRNA concentration (0.11 ng/oocyte), the expressed current inactivates and is fully inhibited by 10 nM CTX. In contrast, at high cRNA concentration (35 ng/oocyte), the current did not inactivate and was insensitive to 10 nM CTX. Honoré et al. (27) thought that at high RNA concentration, the channel interacted differently with the cytoskeleton. The RNA concentration used in our studies were the same (5 ng) for both WT and NT3-39. There were no differences in the activation and inactivation kinetics parameters of mutant and wild type. Furthermore, disruption of the cytoskeleton by cytochalasin D resulted in a similar degree of inhibition of both wild type and mutant channels currents (22). Effect of Deleting the T0 Domain-- It is possible that removal of the T0 domain causes large structural changes in the pore that lead to nonspecific alterations in the affinity of different and structurally unrelated inhibitors. To determine whether this was the case, other known inhibitors of Kv1.3 were tested. As shown in Table I, although NT3-39 displays relative resistance to the effect of CTX, it is inhibited to the same degree as wild type by other known blockers of the channel. These data strongly suggest that the T0 domain interacts specifically with the CTX-binding site.
This effect could be mediated by conformational changes in the pore that physically prevent CTX from reaching its binding site (steric hindrance), resulting in weaker CTX block. For instance, T0 could bind to the intracellular loop between S4, the voltage gate, and S5, the outer helix that form the pore and faces the lipid bilayer. As mentioned above, point mutations of that cytoplasmic loop can significantly alter pore function. Alternatively, T0 could interact to the carboxy end of S6, the inner helix lining the central pore. Although we have no data supporting such a mechanism, there is precedence for the N terminus of a Shaker protein binding to and blocking the intracellular mouth of the pore (13). Further support for the importance of conformational factors is given by the observation that replacing a glycine (60 Å3) found at the mouth of Kv1.3 with larger residues such as glutamine and tyrosine (145-195 Å3) confers resistance to inhibition by CTX. At present we cannot exclude the possibility that T0 modulates CTX binding by interacting with a site close to the pore and inducing a conformational change that strengthens the interaction of CTX to its binding site in the channel pore. Crystallographic information is needed to rigorously test this hypothesis. Effect on Block by Other Inhibitors--
Alternatively, the T0
domain that contains six negative charges and one positive charge (Fig.
1A) could affect the binding of CTX (net valence of +5) to
the pore via through-space electrostatic interactions. Such a mechanism
has been shown to operate over distances of 5-20 Å (9, 29, 30). As
previously mentioned, high affinity binding of CTX depends on
electrostatic interactions of the positively charged toxin with
negatively charged amino acid residues located at the mouth of Shaker
channels. The model predicts that T0 mutants should also be resistant
to other toxins that bind to the pore and inhibit through-space
electrostatic interactions. ShK, a 35-amino acid residue polypeptide
isolated from the sea anemone Stichodactyla helianthus, also
blocks Kv1.3. Its structure is different from that of scorpion toxins.
However, it contains a set of conserved residues (a lysine and a
tyrosine 7 Å apart) that have been shown to be critical for block of
potassium channel by scorpion toxins (31). ShK-DAP22 (a mutant form of ShK) specifically inhibits Kv1.3 by binding to external mouth of pore
region through electrostatic interactions. The potency of 50 pM ShK-DAP22 to inhibit WT and NT3-39 was tested. As shown in Fig. 3, NT3-39 was significantly less
sensitive to inhibition by 50 pM ShK-DAP22 than WT
(NT3-39, 31.4 ± 7%, n = 15; WT, 56.78 ± 6.5, n = 7; p < 0.009).
Effect of Ionic Strength--
The electrostatic model also
predicts that CTX binding should be sensitive to the ionic strength
(i.s.) of the external solution. In WT, negatively charged amino acids
located in the pore region and the T0 domain both contribute to the
overall negative charge of the CTX-binding site. At low ionic strength
the interaction of positively charged CTX with its negatively charged
binding site should be stronger. One would then predict that, as
compared with WT, the affinity CTX for T0 mutants will be less
sensitive to changes in ionic strength. More specifically, as ionic
strength decreases, the increase in affinity of CTX for NT3-39 will be less than that for WT. To test this hypothesis, inhibition of WT and
NT3039 by 1 nM CTX was measured in external solutions of high and low ionic strength. The high i.s. solution contained 88 mM sodium and 2 mM potassium, whereas the low
i.s. bath had 40 mM sodium, 2 mM potassium with
sucrose added to keep tonicity constant. As shown in Fig.
4A, both WT and NT3-39 were
more sensitive to inhibition by CTX at low ionic strength. However, the
increase in CTX sensitivity was far greater for NT3-39 than for WT
(Fig. 4B), suggesting that T0 does not mediate its action
primarily via electrostatic interactions.
Mutation of Charged Amino Acids--
If the T0 domain (net charge
of Heteromultimers of WT and Mutated Channels--
Because the
functional Kv1.3 channel is a homotetramer, it contains four T0 domains
that could potentially interact with the pore. A reduction in the
number of T0 domains present in the functional channel should lead to
the formation of a channel with intermediate CTX sensitivity. This
prediction was tested by co-injecting WT and NT3-39 cRNAs in
Xenopus oocytes and determining the Ki for CTX. We found that WT/NT3-39 current had a Ki
for CTX of 4.8 nM. Heteromultimers of WT and NT3-39 had,
as predicted, an intermediate phenotype, being less sensitive to CTX
inhibition than WT (Ki = 0.5 nM) but
more than NT3-39 (Ki = 9.3 nM) (Fig.
5). Although it is clear that WT and
NT3-39 form heteromultimers, the stoichiometry of each functional
channel is unknown, and, therefore, the contribution of each T0 domain to the stabilization of CTX at its binding site cannot be estimated. However, we can definitively conclude that the CTX sensitivity is
altered in the ensemble.
The crystal structure of the T1 domain of Shaker indicated that it forms a tetrameric structure, and this led to the suggestion that the complex might function as selectivity filter on the cytoplasmic side (32, 33). This hypothesis was not confirmed by recent studies examining the kinetic properties of mutant Shaker potassium channels lacking the entire T1 domain (28). Indeed, although channel expression was significantly reduced compared with wild type, both mutant and wild type had similar kinetic and pharmacologic properties. Of relevance to the present study, sensitivity to CTX was unchanged in the T1 deletion mutants. This discrepancy could be explained by several factors including different Shaker isoforms (Kv1.3 versus Shaker B), markedly different deletions (36 aa versus 205 aa), and use of a CTX variant (CTX-M29L) on Shaker B with a mutated CTX site. Conclusion--
We have previously shown that the T0 domain of
Shaker Kv1.3 regulates steady state channel protein density
in the plasma membrane. Compared with wild type, deleting the T0 domain
leads to a 13-fold amplification of whole cell Kv current, largely by
increasing the absolute number of channel proteins present in the
membrane. Although the T0 domain is located at the N terminus (amino
acids 3-39), the current data strongly suggest that it also interacts with the pore region. Indeed, although T0 does not affect pore selectivity, it does modulate the action of drugs whose binding to the
pore depends in part on electrostatic interactions. Even though the T0
domain has a net negative charge of
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The abbreviations used are: WT, wild type; CTX, charybdotoxin; i.s., ionic strength.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||